Peer Review History
| Original SubmissionMay 15, 2025 |
|---|
|
Dear Dr. Belete, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Csaba Varga, DVM MSc PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please ensure that you refer to Figure 4 in your text as, if accepted, production will need this reference to link the reader to the figure. 3. Please upload a copy of Figure 3, to which you refer in your text on page 14. If the figure is no longer to be included as part of the submission please remove all reference to it within the text. 4. We note that Figure S1 includes an image of a participant / in the study. As per the PLOS ONE policy (http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research) on papers that include identifying, or potentially identifying, information, the individual(s) or parent(s)/guardian(s) must be informed of the terms of the PLOS open-access (CC-BY) license and provide specific permission for publication of these details under the terms of this license. Please download the Consent Form for Publication in a PLOS Journal (http://journals.plos.org/plosone/s/file?id=8ce6/plos-consent-form-english.pdf). The signed consent form should not be submitted with the manuscript, but should be securely filed in the individual's case notes. Please amend the methods section and ethics statement of the manuscript to explicitly state that the patient/participant has provided consent for publication: “The individual in this manuscript has given written informed consent (as outlined in PLOS consent form) to publish these case details”. If you are unable to obtain consent from the subject of the photograph, you will need to remove the figure and any other textual identifying information or case descriptions for this individual. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: N/A Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: 1. All scientific names should be italicised 2. The first sentence of the abstract must be revised based on the title 3. Revise your introduction; the second sentence is unnecessary 4. Study conducted only in one city (Bahir Dar) may not represent northwest Ethiopia, so revise your title and other parts based on the area where the study was conducted Reviewer #2: This manuscript discuss the crossectional study of AMR in non-typhoidal Salmonella. Study has been informed and written well. Som eextreem words such as Salmonella is a devastating disease shoul dbe corrected. Association was observed through chisquare tests. Corrected chisquare test should be calculated for those celss with <5. For bivariate categories, it is better presented the Fisher's exact test rather than chi-square. Reviewer #3: This manuscript reports on an important topic, however, my considered opinion is that this study was low powered and this affected the authors choice of statistical test. This study would have benefited from more rigorous statistical tests to assess the magnitude (strengths) and direction of association between the explanatory variables and the outcome variable. Also, in the design of the study, the authors should have considered the fact that Salmonella is intermittently shed by poultry and should have tested a large number of birds per farm rather than just 126 from 22 farms that had relatively large flock sizes. Abstract Line 43: Consider italicizing “Salmonella” before species and should be consistently done across the manuscript. Line 52-54: Is this a conclusion from your study? The conclusions section of your manuscript needs to be improved. In my view, there are no conclusions drawn from the findings. Real conclusions should be provided here. Line 58: “Occurrence” may not be a useful key word. Why include occurrence as a key word? Introduction Line 61: Be consistent with italicizing the word Salmonella throughout your manuscript. Lines 63-65: I believe you are referring to human deaths. It would be nice to be specific. Line 69: I believe it is not correct to start a statement with an acronym. You might consider writing NTS in full here. Line 83-86: “associated illnesses originated from contaminated poultry” is different from contaminated poultry meat and eggs. Verify your facts and report this correctly. Is the statement on line 83-86 correct? Line 112: S. Kentucky not Kentuck. Line 118: epidemiologic not epidemiological. Methods Line 147: …July 2021) Line 147-148: Consider rephrasing, though grammatically correct, please reconsider the use of the word subjects to refer to chickens in the study. Line 149-150: How did you determine your sample size? I can see that your sample size could have affected your choice of statistical test. Line 150: What was the minimum flock size in the small farms? Line 153-157: Can you provide the questionnaire used as a supplementary file? Line 169-171: It is important to state that the birds were sampled just once. This is important because salmonella shedding can be intermittent, and a negative test is not conclusive. Line 175-177: What was the time between sample collection and submission to the lab? Was this consistent for all samples? How long were the samples stored in iceboxes? Line 195: provide a reference for the guidelines. Line 231: Outlined in what? Mention it before the citation. Line 251-252: Why the Chi-square test? Couldn’t you perform analysis with logistic regression? Did your sample size affect your choice of statistical test? What were you explanatory variables (risk factors talked about)? These need to be described alongside your outcome variable. The Chi-square test does not give the magnitude (strength) of the association and the direction of the association. Explain to the reader the reasons for your choice of statistical test. Results Line 279: How strong was the association? What was the magnitude of the association? Provide the magnitude of the association. You cannot claim the association is strong without providing a measure of the strength of the association i.e. the odds ratio. Line 284: Why use the word salmonella occurrence and not prevalence for consistency? Line 292: Be consistent with your reporting of P-Values. Line 308: Does sensitivity mean low resistance?? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Multidrug-resistant non-typhoidal Salmonella enterica from chickens, farmworkers, and environments: One Health Implications from Northwestern Ethiopia PONE-D-25-25886R1 Dear Dr. Mequanint Addisu Belete, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Csaba Varga, DVM MSc PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewer #1: Reviewer #2: Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. please check the references again, e.g. line 104 check the reference, cancel Taddesse, 2. I have other issues to raise Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No **********
|
| Formally Accepted |
|
PONE-D-25-25886R1 PLOS ONE Dear Dr. Belete, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Csaba Varga Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .